Last updated: July 17, 2026

Application No. 18/696,031

METHOD FOR PREDICTING RESPONSE TO CANCER IMMUNOTHERAPY BY USING DNA METHYLATION ABERRATION IN LINE-1

Non-Final OA

Filed

Mar 27, 2024

Priority

Sep 29, 2021 — RE 10-2021-0128751 +2 more

Examiner

KENNEDY, SARAH JANE

Art Unit

Tech Center

Assignee

Korea Advanced Institute of Science and Technology

OA Round

1 (Non-Final)

Interview Optional

— +0.0% interview lift. Interview lift (+0.0%) is below the 15.0% threshold. A written response is recommended.

Based on 11 resolved cases, 2023–2026

Examiner Intelligence

KENNEDY, SARAH JANE View full profile →

Grants only 0% of cases

Career Allowance Rate

0 granted / 11 resolved

-60.0% vs TC avg

Minimal +0% lift

Without

With

+0.0%

Interview Lift

resolved cases with interview

Typical timeline

3y 8m

Avg Prosecution

31 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§103

75.4%

+35.4% vs TC avg

§102

1.7%

-38.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 11 resolved cases

Prosecution Timeline

Mar 27, 2024

Application Filed

May 28, 2026

Non-Final Rejection mailed (current)

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

Grant Probability

With Interview (+0.0%)

3y 8m (~1y 4m remaining)

Median Time to Grant

Low

PTA Risk

Based on 11 resolved cases by this examiner. Grant probability derived from career allowance rate.